Expression Analysis of microRNAs in Peripheral Blood Mononuclear Cells in Type 2 Diabetes
8 affiliations
- 1Institute of Biochemistry and Genetics, Ufa Federal Research Centre, Russian Academy of Sciences, 450054 Ufa, Russia
- 2Department of Medical Genetics and Fundamental Medicine, Faculty of General Medicine, Bashkir State Medical University, 450008 Ufa, Russia
- 3Department of Biology, Faculty of Stomatology, Bashkir State Medical University, 450008 Ufa, Russia
- 4Laboratory of Microfluidic Technology, Institute of Fundamental Medicine, Bashkir State Medical University, 450008 Ufa, Russia
- 5Laboratory of Cell Cultures, Institute of Fundamental Medicine, Bashkir State Medical University, 450008 Ufa, Russia
- 6Department of Endocrinology, Faculty of General Medicine, Bashkir State Medical University, 450008 Ufa, Russia
- 7Section of Statistical Multi-Omics, Department of Clinical & Experimental Medicine, School of Biosciences & Medicine, University of Surrey, Guildford GU2 7XH, UK
- 8Department of Psychology, Middlesex University, London NW4 4BT, UK
Abstract
MicroRNAs (miRNAs) are involved in the regulation of glucose metabolism and inflammatory processes associated with type 2 diabetes (T2D) and have potential as biomarkers and therapeutic targets. We analysed the expression of miR-155-5p, miR-141-3p, miR-15b-5p, miR-18a-5p, and miR-379-5p in peripheral blood mononuclear cells (PBMCs) from 79 patients with T2D and 88 non-diabetic controls. Differential expression analysis revealed significant downregulation of miR-15b-5p, miR-155-5p, and miR-18a-5p, and significant upregulation of miR-379-5p in T2D patients. Among the individual miRNAs, miR-15b-5p showed the highest ability to distinguish between T2D and controls (AUC = 0.82, 95% CI 0.76–0.89, p = 0.001). A model combining the four differentially expressed miRNAs (miR-155-5p, miR-15b-5p, miR-18a-5p, and miR-379-5p) with age, sex, and BMI had an AUC of 0.98, compared with 0.93 for age, sex, and BMI alone (p = 0.004, paired DeLong test); the optimism-corrected AUC was 0.97, although the bootstrap procedure did not account for optimism arising from miRNA selection. Functional enrichment analysis identified MAPK, Hippo, FoxO, insulin, AMPK and TGF-β signalling as consistently enriched across analyses based on experimentally supported and predicted miRNA targets.
Related
- Peripheral Blood Mononuclear Cell Expression Profile of Proliferation-, Ferroptosis-, and Immune-Related Targets in Breast Cancer.
- Cryopreserved Peripheral Blood Mononuclear Cells Recover Mitochondrial Function Following Overnight Culture Revealed by High-Resolution Respirometry
- Comparative Effects of Acrolein and Glyoxal on Redox Homeostasis, Antioxidant Defense and Membrane Properties in Human Peripheral Blood Mononuclear Cells: An In Vitro Study.
- Quantification of Y RNAs in peripheral blood mononuclear cells from patients with ankylosing spondylitis and healthy controls.
- Lidocaine modulates interleukin-1β and interferon-α2 secretion in LPS with ATP stimulated human peripheral blood mononuclear cells
BibTeX
@article{timasheva2026expression,
title = {{Expression Analysis of microRNAs in Peripheral Blood Mononuclear Cells in Type 2 Diabetes}},
author = {Yanina Timasheva and Olga Kochetova and Vitaly A. Markelov and Ksenia V. Danilko and Tatyana M. Kochetova and Diana Avzaletdinova and Gulnaz F. Korytina and Zhanna Balkhiyarova and Arie Nouwen},
journal = {Biomolecules},
year = {2026},
month = oct,
doi = {10.3390/biom16101503},
url = {https://www.mdpi.com/2218-273X/16/10/1503},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Expression Analysis of microRNAs in Peripheral Blood Mononuclear Cells in Type 2 Diabetes
AU - Yanina Timasheva
AU - Olga Kochetova
AU - Vitaly A. Markelov
AU - Ksenia V. Danilko
AU - Tatyana M. Kochetova
AU - Diana Avzaletdinova
AU - Gulnaz F. Korytina
AU - Zhanna Balkhiyarova
AU - Arie Nouwen
PY - 2026
DA - 2026/10/01
JO - Biomolecules
DO - 10.3390/biom16101503
UR - https://www.mdpi.com/2218-273X/16/10/1503
AB - MicroRNAs (miRNAs) are involved in the regulation of glucose metabolism and inflammatory processes associated with type 2 diabetes (T2D) and have potential as biomarkers and therapeutic targets. We analysed the expression of miR-155-5p, miR-141-3p, miR-15b-5p, miR-18a-5p, and miR-379-5p in peripheral blood mononuclear cells (PBMCs) from 79 patients with T2D and 88 non-diabetic controls. Differential expression analysis revealed significant downregulation of miR-15b-5p, miR-155-5p, and miR-18a-5p, and significant upregulation of miR-379-5p in T2D patients. Among the individual miRNAs, miR-15b-5p showed the highest ability to distinguish between T2D and controls (AUC = 0.82, 95% CI 0.76–0.89, p = 0.001). A model combining the four differentially expressed miRNAs (miR-155-5p, miR-15b-5p, miR-18a-5p, and miR-379-5p) with age, sex, and BMI had an AUC of 0.98, compared with 0.93 for age, sex, and BMI alone (p = 0.004, paired DeLong test); the optimism-corrected AUC was 0.97, although the bootstrap procedure did not account for optimism arising from miRNA selection. Functional enrichment analysis identified MAPK, Hippo, FoxO, insulin, AMPK and TGF-β signalling as consistently enriched across analyses based on experimentally supported and predicted miRNA targets.
SN - 2218-273X
ER -